The Arizona Controlled Substances Prescription Monitoring Program (“PMP”) was established in 2007 and provides the State of Arizona with a central database to track the dispensing of controlled substances. The PMP is designed to assist providers in making better-informed decisions and help “prevent the diversion and misuse of controlled substances at the provider, pharmacy, and…
On December 26, 2024, the U.S. Court of Appeals for the Fifth Circuit vacated its prior December 23, 2024 decision to stay the December 3, 2024 preliminary injunction that temporarily blocked enforcement of the Corporate Transparency Act (“CTA”) and its reporting rule on a nationwide basis. As of the date of this notice and on…
On December 23, 2024, the U.S. Court of Appeals for the Fifth Circuit stayed the December 3, 2024 preliminary injunction that temporarily blocked enforcement of the Corporate Transparency Act (“CTA”) and its reporting rule on a nationwide basis. As of the date of this notice, the CTA has been reinstated nationwide. In light of…
On December 3, 2024, the U.S. District Court for the Eastern District of Texas issued a preliminary injunction, temporarily blocking enforcement of the Corporate Transparency Act (“CTA”) and its reporting rule on a nationwide basis.[1] For the time being, the preliminary injunction means reporting companies are not required to comply with the CTA’s reporting requirements…
Written by: Ian M. Stanford and Steven T. Lawrence If your business includes any sort of subscription-based or membership model, a new federal regulation may change how your customers cancel their subscription or membership. On October 16, 2024, the Federal Trade Commission announced its final “Click-to-Cancel” rule. The new rule applies to “negative option programs,”…
In July and September 2024, FinCEN provided some additional guidance on the Corporate Transparency Act (“CTA”) by updating its Frequently Asked Questions web page related to beneficial ownership information report filing obligations of terminated, administratively dissolved and disregarded entities, and clarifying the contents of such beneficial ownership information report filings. Below is a brief summary…
The materials provided in this website are for informational purposes only and are not for the purpose of providing legal advice. Transmission of information from the ML website is not intended to create, and its receipt by you does not create an attorney-client relationship with ML or any of its individual attorneys or personnel.
If you elect to communicate with anyone at ML through this website, or otherwise, in connection with a matter for which we do not already represent you, your communication can not be treated as privileged or confidential. Do not transmit any information about any matter (and particularly not information you regard as confidential) that may involve you until ML has agreed to represent you, and you have received confirmation of that fact in the form of a written engagement letter.